Spinel ferrite crystals are widely explored for magnetic hyperthermia, yet the design of crystal-chemistry “thermal brakes” that prevent overheating remains underdeveloped. Here we report a crystal structure-driven strategy to tune heating performance in hafnium-substituted magnetite nanocrystals, Hf_xFe_3-xO₄ ( x = 0.4, 0.6), synthesized by a scalable reverse co-precipitation route. X-ray diffraction confirms the cubic spinel structure across the series and reveals a systematic shift of the (311) reflection toward lower 2θ with increasing Hf content, consistent with lattice expansion and distortion induced by aliovalent substitution. The lattice parameter increases monotonically, while the coherent crystallite size decreases (≈10.6 → 7.9 nm), indicating enhanced microstructural disorder at higher substitution levels. Transmission electron microscopy shows quasi-spherical particles with comparable physical sizes (~12–14 nm), supporting a model where a reduced crystalline coherence length (rather than gross particle growth) governs structure–property changes. Magnetization measurements evidence a progressive decrease in saturation magnetization with Hf incorporation, consistent with modified cation distribution and increased surface/spin disorder. Under alternating magnetic field excitation, the specific absorption rate (SAR) decreases from pristine magnetite to Hf-doped (e.g., ~39.4 to ~8.1 W g^-1), yielding a controllable heating response that mitigates the risk of surpassing the therapeutic window. Baseline in vitro assays in MDA-MB-231 breast cancer cells (without AMF) support cytocompatibility within the tested concentration range, complementing prior ISO-guided viability results in non-tumor cells. Overall, these results establish lattice distortion and crystalline coherence as practical design knobs to engineer safer, dose-controlled hyperthermia agents based on spinel nanocrystals.